FacebookTwitterGoogle+RedditEmail

Kicking the Wyeth Habit Saves Women’s Lives

An editorial cartoon from the summer of 2002 shows a TV announcer leading a newscast with: “A major US drug maker is warning women if they stop hormone therapy abruptly, its stock price will fall.”

Wyeth, maker of Prempro and Premarin, has indeed seen its stock price fall since the news from a study presented at a breast cancer conference in San Antonio in December broke that breast cancer fell 7% from 2002 to 2003 and estrogen positive breast cancer, 15%, presumably because women went off HRT.

And just as the initial Women’s Health Initiative HRT findings drew a chorus of “yes buts” from those financially linked to HRT–the women in the study were “too old”, took HRT too long, should have taken only one hormone, shouldn’t have had heart disease–already spins and denials are coming out.

Maybe the number of breast cancers hasn’t dropped at all, opined experts quoted by ABC News Medical Unit, but mammograms have dropped. (Or the population dropped 15%–did they think of that?)

Withdrawing hormones couldn’t produce a decrease in breast cancer that quickly, say other sources though estrogen-fueled cancers can indeed regress, not form at all or not become mammogram detectable in three years, says New York Times science reporter Gina Kolata.

Others are ranting that news like this could scare women away from legitimate HRT uses. Many have just returned from the FDA hearings on antidepressant warnings where they said the same thing.

Unfortunately, HRT loyalists have more than the M.D. Anderson Cancer Center study which broke the news to refute. A November study in the Journal of Clinical Oncology found an even larger drop in breast cancer rates in California where there was also a larger drop in HRT use.

And epidemiologists at the Northern California Cancer Center found breast cancer down 11% in 2004 using data from a National Cancer Institute program and from Kaiser Permanente.

Despite the fact that HRT was found in 2002 to cause a 26% increased risk of breast cancer, 29% increased risk of heart attack, 41% increased risk of stroke, and 100% increased risk of blood clots, Wyeth continues to market Prempro and Premarin. Especially because it faces 3600 legal cases and withdrawing or discontinuing the drugs would be an admission of guilt.

Not that they don’t already look complicit.

Testimony in an Arkansas breast cancer trial this year revealed that a Wyeth salesman wrote company executives in 2000, “The desire for increased sales has overruled our company’s ethical responsibility to promote our products safely.” He also testified that Wyeth Chairman and CEO Robert Essner told his reps at a Prempro launch party the company was creating an “HRT revolution” that would keep women on the drug from menopause to death and that there should be “no boundaries, no limits to your selling effort.”

But the latest news makes it even tougher for Wyeth to plead ignorance. With 14,000 women who were expected to get breast cancer NOT GETTING IT as analysts now claim, quitting HRT practically looks like the cure.

And what possible warning label could you put on a drug that is apparently so deadly and works so fast, anyway? That if you go off it, the manufacturer’s stock price will fall?

MARTHA ROSENBERG is a Staff Cartoonist at the Evanston Roundtable. Her work has appeared in the Chicago Tribune, LA Times, San Francisco Chronicle, Boston Globe, Providence Journal. Arizona Republic, New Orleans Times-Picayune and other newspapers.  She can be reached at: mrosenberg@evmark.org

 

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

Weekend Edition
August 17, 2018
Friday - Sunday
Nick Pemberton
Donald Trump and the Rise of Patriotism 
CJ Hopkins
Where Have All the Nazis Gone?
Joseph Natoli
First Amendment Rights and the Court of Popular Opinion
Andrew Levine
Midterms 2018: What’s There to Hope For?
Jeffrey St. Clair
Roaming Charges: Running Out of Fools
Ajamu Baraka
Opposing Bipartisan Warmongering is Defending Human Rights of the Poor and Working Class
Paul Street
Corporate Media: the Enemy of the People
David Macaray
Trump and the Sex Tape
Daniel Falcone
The Future of NATO: an Interview With Richard Falk
Robert Hunziker
Hothouse Earth
Cesar Chelala
The Historic Responsibility of the Catholic Church
Ron Jacobs
The Barbarism of US Immigration Policy
Kenneth Surin
In Shanghai
William Camacaro - Frederick B. Mills
The Military Option Against Venezuela in the “Year of the Americas”
Nancy Kurshan
The Whole World Was Watching: Chicago ’68, Revisited
Robert Fantina
Yemeni and Palestinian Children
Alexandra Isfahani-Hammond
Orcas and Other-Than-Human Grief
Shoshana Fine – Thomas Lindemann
Migrants Deaths: European Democracies and the Right to Not Protect?
Paul Edwards
Totally Irrusianal
Thomas Knapp
Murphy’s Law: Big Tech Must Serve as Censorship Subcontractors
Mark Ashwill
More Demons Unleashed After Fulbright University Vietnam Official Drops Rhetorical Bombshells
Ralph Nader
Going Fundamental Eludes Congressional Progressives
Hans-Armin Ohlmann
My Longest Day: How World War II Ended for My Family
Matthew Funke
The Nordic Countries Aren’t Socialist
Daniel Warner
Tiger Woods, Donald Trump and Crime and Punishment
Dave Lindorff
Mainstream Media Hypocrisy on Display
Jeff Cohen
Democrats Gather in Chicago: Elite Party or Party of the People?
Victor Grossman
Stand Up With New Hope in Germany?
Christopher Brauchli
A Family Affair
Jill Richardson
Profiting From Poison
Patrick Bobilin
Moving the Margins
Alison Barros
Dear White American
Celia Bottger
If Ireland Can Reject Fossil Fuels, Your Town Can Too
Ian Scott Horst
Less Voting, More Revolution
Peter Certo
Trump Snubbed McCain, Then the Media Snubbed the Rest of Us
Dan Ritzman
Drilling ANWR: One of Our Last Links to the Wild World is in Danger
Brandon Do
The World and Palestine, Palestine and the World
Negin Owliaei
Toys R Us May be Gone, But Its Workers’ Struggle Continues
Chris Wright
An Updated and Improved Marxism
Daryan Rezazad
Iran and the Doomsday Machine
Patrick Bond
Africa’s Pioneering Marxist Political Economist, Samir Amin (1931-2018)
Louis Proyect
Memoir From the Underground
Binoy Kampmark
Meaningless Titles and Liveable Cities: Melbourne Loses to Vienna
Andrew Stewart
Blackkklansman: Spike Lee Delivers a Masterpiece
Elizabeth Lennard
Alan Chadwick in the Budding Grove: Story Summary for a Documentary Film
FacebookTwitterGoogle+RedditEmail